SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-23-026526
Filing Date
2023-09-21
Accepted
2023-09-21 16:28:00
Documents
17
Period of Report
2023-09-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ctdh20230920_8k.htm   iXBRL 8-K 48051
2 EXHIBIT 2.1 ex_572013.htm EX-2.1 756898
3 EXHIBIT 10.1 ex_572014.htm EX-10.1 47556
4 EXHIBIT 99.1 ex_572019.htm EX-99.1 23276
9 logo.jpg GRAPHIC 7755
  Complete submission text file 0001437749-23-026526.txt   1198686

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA ctdh-20230921.xsd EX-101.SCH 3891
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ctdh-20230921_def.xml EX-101.DEF 13443
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE ctdh-20230921_lab.xml EX-101.LAB 17670
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ctdh-20230921_pre.xml EX-101.PRE 13420
11 EXTRACTED XBRL INSTANCE DOCUMENT ctdh20230920_8k_htm.xml XML 4405
Mailing Address PO BOX 1180 ALACHUA FL 32616-1180
Business Address 6714 NW 16TH STREET, SUITE B GAINESVILLE FL 32653 386-418-8060
Cyclo Therapeutics, Inc. (Filer) CIK: 0000922247 (see all company filings)

IRS No.: 593029743 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39780 | Film No.: 231269394
SIC: 2836 Biological Products, (No Diagnostic Substances)